SlideShare a Scribd company logo
FORECASTING
MORBIDITY METHOD
DR. MOE KYAW KYAW
GHSC-PSM, MYANMAR
MARCH, 2017
Morbidity Method
o Uses the frequency/ies of disease occurrence in
the population or Incidence/prevalence of
diseases
o Requires standard treatment guidelines (STGs)
o Best approach for justifying a budget request
o Suitable for use where consumption data is not
available
o New treatment therapy, formulation, guideline,
policies, new programs
2
Data Requirement for Morbidity
method
• List of health commodities with minimum
specifications
• Morbidity data –
o Target population, Incidence and/or prevalence of disease or
frequency of the disease
o Scaling up plan
o Regimens and formulations used and respective proportions
o Attrition Rates for chronic diseases
• Standard treatment guidelines, including generic
drug and dosing schedules
3
Assumption and limitations – 1
4
Assumptions Limitations
1. The historical disease
patterns remain the
same in forecasted
period
 Not accurate for irregular disease
pattern
2. Morbidity
data/reports are
accurate and
comprehensive
 Not accurate if reporting rate is
low, the estimated disease frequency
could be lower than actual
Assumption and limitations – 2
5
Assumptions Limitations
3. Needs assumptions for
• Scaling up plan and targets
• Attrition rates
• Failure rates
• Proportion of treatments
 Complex calculation especially
for chronic diseases. Time
consuming and computer
analysis may need
4. STG exists and the treatment
services follows the guideline
 Not applicable if there is no STG
 Not accurate, if the services do
not follow the STG
CALCULATION STEPS
MORBIDITY METHOD
6
Step 1: Establish the list of medicines
to be quantified
Generic Names of medicines with minimum
specifications of:
◦ Strength
◦ Basic Unit
◦ Form
◦ Accounting units
◦ Price per accounting unit
Other specification for analysis
◦ Item categories
◦ VEN status
◦ Suppliers
7
Step 2: Categorize the diseases to be
addressed with this quantification
Disease classification can be at different levels
Example:
Level 1 classification
o Infectious, Non-infectious diseases
Level 2 classification
o Pneumonia, Malaria, TB
o Hypertension, Diabetes
8
Step 3: Calculating the Quantity required
to treat an episode of the disease
QE = DBU × ND × LD
QE = Quantity needed for each treatment episode
DBU = Basic units (of the product) per dose/administration
ND = Number of doses per day
•LD = Length of treatment in days
DBU = DAD ÷ SPR
DAD = Dosage per administration of medicine. E.g. 500mg
SPR = Strength of product. E.g. 250mg
9
Example for step 3 – Acute Cases
One treatment for pneumonia includes
o 500mg Amoxicillin, 3 times per day for 7 days
o Available 250mg tablet
QE = (DAD ÷ SPR) × ND × LD
QE = (500 ÷ 250) x 3 x 7
QE = 2 x 3 x 7 = 42 tablets
10
Example for step 3 – Chronic Cases (ARV)
For regimen AZT/3TC/EFV
o AZT+3TC (300+150)mg 2 times/day
o EFV (600)mg 1 time/day
AZT+3TC = 1 × 2 × 30 = 60 tabs/month
EFV = 1 × 1 × 30 = 30 tabs/month
11
Step 4: Calculate numbers of Estimated cases
per month for each health condition during
forecasted period
For Acute Cases
Incidence: # of new cases/diseases in a period
Prevalence: # of all cases/diseases in a period
Number of treatment (Episodes)
Example:
Prevalence of 12 cases/1,000 in 100,000 population
Disease episodes = (12 x 100,000)/1,000 = 1200/yr
Estimated cases per month (ECM) =1200/12 = 100
12
Scaling-up for chronic cases (ARV)
13
10 20 30 40
Total patients treated per month
(Patient-months) 
10 10
10 10
10
10
10
10
10
10
Jan Feb Mar Apr
Total person-months for all period  10+20+30+40 = 100
Number of ARVs = ARV/day x 30.5 x 100
Step 5. Calculate the total quantity of each
commodity required for the forecast period
QT = ECM x FP x QE
QT = Total quantities
ECM = Expected Cases Per month
FP = Forecast period in months
QE = Quantity needed for each treatment episode
E.g. 4 month forecast quantities for acute cases
 QT = 100 x 4 X 42 = 16,800 tabs
E.g. 4 month forecast quantities for chronic cases
 QT for AZT/3TC = 100 x 60 = 6,000 tabs
 QT for EFV = 100 x 1 x 30 = 3,000 tabs
14
42 tabs/ full treatment course
AZT/3TC → 60 tabs/month
EFV → 30 tabs/month
Step 6: Calculate the cost of each
commodity required for the period
CT = QT x Unit Cost
CT = Total cost of product for forecast period
Example: CT for Amoxicillin 250mg cap
= 16,800 x 20 = 33,600 Kyats
15

More Related Content

What's hot

Therapeutic Drug Monitoring
 Therapeutic Drug Monitoring Therapeutic Drug Monitoring
Therapeutic Drug MonitoringRajat Mahamana
 
Hosptal pharmacy management
Hosptal pharmacy management Hosptal pharmacy management
Hosptal pharmacy management
Pravindas Vaishnav
 
Developing therapeutic guidelines
Developing therapeutic guidelines  Developing therapeutic guidelines
Developing therapeutic guidelines
Irene Vadakkan
 
Inventory management of a hospital pharmacy
Inventory management of a hospital pharmacyInventory management of a hospital pharmacy
Inventory management of a hospital pharmacy
Toukir Ahamed
 
Inventory control
Inventory controlInventory control
Inventory control
katta amulya
 
Abc analysis of given list of medication
Abc analysis of given list of medication Abc analysis of given list of medication
Abc analysis of given list of medication
Rafi Bhat
 
14ab1t0017 procurement and warehousing of radiopharmaceuticals
14ab1t0017   procurement and warehousing of radiopharmaceuticals14ab1t0017   procurement and warehousing of radiopharmaceuticals
14ab1t0017 procurement and warehousing of radiopharmaceuticals
Ramesh Ganpisetti
 
Ppt of pharmaceutical economy
Ppt of pharmaceutical economyPpt of pharmaceutical economy
Ppt of pharmaceutical economy
Muhammed hamed albuissa
 
Abc Analysis
Abc AnalysisAbc Analysis
Abc Analysis
PrinceGauravTiwari
 
Purchasing and inventory control in drug store
Purchasing and inventory control in drug storePurchasing and inventory control in drug store
Purchasing and inventory control in drug store
Priyanka Kalamkar
 
14ab1t0007 continuing professional development programs
14ab1t0007   continuing professional development programs14ab1t0007   continuing professional development programs
14ab1t0007 continuing professional development programs
Ramesh Ganpisetti
 
14ab1 t0014 infection control committee and research & ethics committee
14ab1 t0014  infection control committee and research & ethics committee14ab1 t0014  infection control committee and research & ethics committee
14ab1 t0014 infection control committee and research & ethics committee
Ramesh Ganpisetti
 
1. Pharmacy management cycle
1. Pharmacy management cycle1. Pharmacy management cycle
1. Pharmacy management cycle
Muwanguzi Daniel
 
Establishing a drug information centre
Establishing a drug information centreEstablishing a drug information centre
Establishing a drug information centre
Khadga Raj
 
Rud
RudRud
Drug Information Services
Drug Information ServicesDrug Information Services
Drug Information Services
Dr.Amreen Saba Attariya
 
14ab1t0009 newsletter
14ab1t0009    newsletter14ab1t0009    newsletter
14ab1t0009 newsletter
Ramesh Ganpisetti
 
Inventory management rqm, eoq, im
Inventory management rqm, eoq, imInventory management rqm, eoq, im
Inventory management rqm, eoq, im
chiranjibi68
 
Ward round participation
Ward round participationWard round participation
Ward round participation
Sarah Pulackal
 
Inventory control
Inventory controlInventory control
Inventory control
Dr. J.P. Rajliwal
 

What's hot (20)

Therapeutic Drug Monitoring
 Therapeutic Drug Monitoring Therapeutic Drug Monitoring
Therapeutic Drug Monitoring
 
Hosptal pharmacy management
Hosptal pharmacy management Hosptal pharmacy management
Hosptal pharmacy management
 
Developing therapeutic guidelines
Developing therapeutic guidelines  Developing therapeutic guidelines
Developing therapeutic guidelines
 
Inventory management of a hospital pharmacy
Inventory management of a hospital pharmacyInventory management of a hospital pharmacy
Inventory management of a hospital pharmacy
 
Inventory control
Inventory controlInventory control
Inventory control
 
Abc analysis of given list of medication
Abc analysis of given list of medication Abc analysis of given list of medication
Abc analysis of given list of medication
 
14ab1t0017 procurement and warehousing of radiopharmaceuticals
14ab1t0017   procurement and warehousing of radiopharmaceuticals14ab1t0017   procurement and warehousing of radiopharmaceuticals
14ab1t0017 procurement and warehousing of radiopharmaceuticals
 
Ppt of pharmaceutical economy
Ppt of pharmaceutical economyPpt of pharmaceutical economy
Ppt of pharmaceutical economy
 
Abc Analysis
Abc AnalysisAbc Analysis
Abc Analysis
 
Purchasing and inventory control in drug store
Purchasing and inventory control in drug storePurchasing and inventory control in drug store
Purchasing and inventory control in drug store
 
14ab1t0007 continuing professional development programs
14ab1t0007   continuing professional development programs14ab1t0007   continuing professional development programs
14ab1t0007 continuing professional development programs
 
14ab1 t0014 infection control committee and research & ethics committee
14ab1 t0014  infection control committee and research & ethics committee14ab1 t0014  infection control committee and research & ethics committee
14ab1 t0014 infection control committee and research & ethics committee
 
1. Pharmacy management cycle
1. Pharmacy management cycle1. Pharmacy management cycle
1. Pharmacy management cycle
 
Establishing a drug information centre
Establishing a drug information centreEstablishing a drug information centre
Establishing a drug information centre
 
Rud
RudRud
Rud
 
Drug Information Services
Drug Information ServicesDrug Information Services
Drug Information Services
 
14ab1t0009 newsletter
14ab1t0009    newsletter14ab1t0009    newsletter
14ab1t0009 newsletter
 
Inventory management rqm, eoq, im
Inventory management rqm, eoq, imInventory management rqm, eoq, im
Inventory management rqm, eoq, im
 
Ward round participation
Ward round participationWard round participation
Ward round participation
 
Inventory control
Inventory controlInventory control
Inventory control
 

Similar to 03. forecasting morbidity method

Measurement of outcomes in epidemiology
Measurement of outcomes in epidemiologyMeasurement of outcomes in epidemiology
Measurement of outcomes in epidemiology
Dr. Ankit Gaur
 
Impact of Antidepressant Medication Adherence on Health Services Utilization ...
Impact of Antidepressant Medication Adherence on Health Services Utilization ...Impact of Antidepressant Medication Adherence on Health Services Utilization ...
Impact of Antidepressant Medication Adherence on Health Services Utilization ...M. Christopher Roebuck
 
Screening for disease.ppt
Screening for disease.pptScreening for disease.ppt
Screening for disease.ppt
rambhapathak
 
Treat to target in inflammatory diseases SMMI 2018
Treat to target in inflammatory diseases SMMI 2018Treat to target in inflammatory diseases SMMI 2018
Treat to target in inflammatory diseases SMMI 2018
SMMI2015
 
Measurement of outcome v5
Measurement  of outcome v5Measurement  of outcome v5
Measurement of outcome v5
aiswarya thomas
 
OUTCOME MEASURES & DRUG USE MEASURE.pptx
OUTCOME MEASURES & DRUG USE MEASURE.pptxOUTCOME MEASURES & DRUG USE MEASURE.pptx
OUTCOME MEASURES & DRUG USE MEASURE.pptx
Asiya Naaz
 
Measurement of outcomes in pharacoepidemiology
Measurement of outcomes in pharacoepidemiologyMeasurement of outcomes in pharacoepidemiology
Measurement of outcomes in pharacoepidemiology
Dr. Ashish singh parihar
 
Treatment of Tuberculosis
Treatment of TuberculosisTreatment of Tuberculosis
Treatment of Tuberculosis
Gyanshankar Mishra
 
10. SOP of QGPs.pptx
10. SOP of QGPs.pptx10. SOP of QGPs.pptx
10. SOP of QGPs.pptx
TunTunWin34
 
S2 Basics of Epidemiology.pptx
S2 Basics of Epidemiology.pptxS2 Basics of Epidemiology.pptx
S2 Basics of Epidemiology.pptx
MunnajiMavatkar
 
Non-Compliance.pptxaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
Non-Compliance.pptxaaaaaaaaaaaaaaaaaaaaaaaaaaaaaNon-Compliance.pptxaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
Non-Compliance.pptxaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
RehanRustam2
 
MDR/XDR by Dr Tasleem Arif
MDR/XDR by Dr Tasleem ArifMDR/XDR by Dr Tasleem Arif
MDR/XDR by Dr Tasleem Arif
TASLEEM ARIF
 
Mdr, xdr by dr tasleem arif
Mdr, xdr by dr tasleem arifMdr, xdr by dr tasleem arif
Mdr, xdr by dr tasleem arif
TASLEEM ARIF
 
Operationalizing Value in Swedish Rheumatology
Operationalizing Value in Swedish RheumatologyOperationalizing Value in Swedish Rheumatology
Operationalizing Value in Swedish Rheumatology
Anna Essén
 
Finding the future of IBD Care in Banking
Finding the future of IBD Care in BankingFinding the future of IBD Care in Banking
Finding the future of IBD Care in Banking
Fredrik Öhrn
 
Inmnoterapia en cáncer urológico - Lo que el urólogo debe saber
Inmnoterapia en cáncer urológico - Lo que el urólogo debe saberInmnoterapia en cáncer urológico - Lo que el urólogo debe saber
Inmnoterapia en cáncer urológico - Lo que el urólogo debe saber
Mauricio Lema
 
Tuberculosis treatment.pptx
Tuberculosis treatment.pptxTuberculosis treatment.pptx
Tuberculosis treatment.pptx
Sushil Humane
 
Annual ed core measures.09 10
Annual ed core measures.09 10Annual ed core measures.09 10
Annual ed core measures.09 10
capstonerx
 
New Drugs and Novel Approaches to Treatment Shortening for Drug-Susceptible a...
New Drugs and Novel Approaches to Treatment Shortening for Drug-Susceptible a...New Drugs and Novel Approaches to Treatment Shortening for Drug-Susceptible a...
New Drugs and Novel Approaches to Treatment Shortening for Drug-Susceptible a...
UC San Diego AntiViral Research Center
 
RNTCP Changes in 2018
RNTCP Changes in 2018RNTCP Changes in 2018
RNTCP Changes in 2018
TanveerRehman4
 

Similar to 03. forecasting morbidity method (20)

Measurement of outcomes in epidemiology
Measurement of outcomes in epidemiologyMeasurement of outcomes in epidemiology
Measurement of outcomes in epidemiology
 
Impact of Antidepressant Medication Adherence on Health Services Utilization ...
Impact of Antidepressant Medication Adherence on Health Services Utilization ...Impact of Antidepressant Medication Adherence on Health Services Utilization ...
Impact of Antidepressant Medication Adherence on Health Services Utilization ...
 
Screening for disease.ppt
Screening for disease.pptScreening for disease.ppt
Screening for disease.ppt
 
Treat to target in inflammatory diseases SMMI 2018
Treat to target in inflammatory diseases SMMI 2018Treat to target in inflammatory diseases SMMI 2018
Treat to target in inflammatory diseases SMMI 2018
 
Measurement of outcome v5
Measurement  of outcome v5Measurement  of outcome v5
Measurement of outcome v5
 
OUTCOME MEASURES & DRUG USE MEASURE.pptx
OUTCOME MEASURES & DRUG USE MEASURE.pptxOUTCOME MEASURES & DRUG USE MEASURE.pptx
OUTCOME MEASURES & DRUG USE MEASURE.pptx
 
Measurement of outcomes in pharacoepidemiology
Measurement of outcomes in pharacoepidemiologyMeasurement of outcomes in pharacoepidemiology
Measurement of outcomes in pharacoepidemiology
 
Treatment of Tuberculosis
Treatment of TuberculosisTreatment of Tuberculosis
Treatment of Tuberculosis
 
10. SOP of QGPs.pptx
10. SOP of QGPs.pptx10. SOP of QGPs.pptx
10. SOP of QGPs.pptx
 
S2 Basics of Epidemiology.pptx
S2 Basics of Epidemiology.pptxS2 Basics of Epidemiology.pptx
S2 Basics of Epidemiology.pptx
 
Non-Compliance.pptxaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
Non-Compliance.pptxaaaaaaaaaaaaaaaaaaaaaaaaaaaaaNon-Compliance.pptxaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
Non-Compliance.pptxaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
MDR/XDR by Dr Tasleem Arif
MDR/XDR by Dr Tasleem ArifMDR/XDR by Dr Tasleem Arif
MDR/XDR by Dr Tasleem Arif
 
Mdr, xdr by dr tasleem arif
Mdr, xdr by dr tasleem arifMdr, xdr by dr tasleem arif
Mdr, xdr by dr tasleem arif
 
Operationalizing Value in Swedish Rheumatology
Operationalizing Value in Swedish RheumatologyOperationalizing Value in Swedish Rheumatology
Operationalizing Value in Swedish Rheumatology
 
Finding the future of IBD Care in Banking
Finding the future of IBD Care in BankingFinding the future of IBD Care in Banking
Finding the future of IBD Care in Banking
 
Inmnoterapia en cáncer urológico - Lo que el urólogo debe saber
Inmnoterapia en cáncer urológico - Lo que el urólogo debe saberInmnoterapia en cáncer urológico - Lo que el urólogo debe saber
Inmnoterapia en cáncer urológico - Lo que el urólogo debe saber
 
Tuberculosis treatment.pptx
Tuberculosis treatment.pptxTuberculosis treatment.pptx
Tuberculosis treatment.pptx
 
Annual ed core measures.09 10
Annual ed core measures.09 10Annual ed core measures.09 10
Annual ed core measures.09 10
 
New Drugs and Novel Approaches to Treatment Shortening for Drug-Susceptible a...
New Drugs and Novel Approaches to Treatment Shortening for Drug-Susceptible a...New Drugs and Novel Approaches to Treatment Shortening for Drug-Susceptible a...
New Drugs and Novel Approaches to Treatment Shortening for Drug-Susceptible a...
 
RNTCP Changes in 2018
RNTCP Changes in 2018RNTCP Changes in 2018
RNTCP Changes in 2018
 

More from Mmedsc Hahm

Solid waste-management-2858710
Solid waste-management-2858710Solid waste-management-2858710
Solid waste-management-2858710
Mmedsc Hahm
 
Situation analysis
Situation analysisSituation analysis
Situation analysis
Mmedsc Hahm
 
Quality in hospital
Quality in hospitalQuality in hospital
Quality in hospital
Mmedsc Hahm
 
Patient satisfaction & quality in health care (16.3.2016) dr.nyunt nyunt wai
Patient satisfaction & quality in health care (16.3.2016) dr.nyunt nyunt waiPatient satisfaction & quality in health care (16.3.2016) dr.nyunt nyunt wai
Patient satisfaction & quality in health care (16.3.2016) dr.nyunt nyunt wai
Mmedsc Hahm
 
Organising
OrganisingOrganising
Organising
Mmedsc Hahm
 
Nscbl slide
Nscbl slideNscbl slide
Nscbl slide
Mmedsc Hahm
 
Introduction to hahm 2017
Introduction to hahm 2017Introduction to hahm 2017
Introduction to hahm 2017
Mmedsc Hahm
 
Hss lecture 2016 jan
Hss lecture 2016 janHss lecture 2016 jan
Hss lecture 2016 jan
Mmedsc Hahm
 
Hospital management17
Hospital management17Hospital management17
Hospital management17
Mmedsc Hahm
 
Hopital stat
Hopital statHopital stat
Hopital stat
Mmedsc Hahm
 
Health planning approaches hahm 17
Health planning approaches hahm 17Health planning approaches hahm 17
Health planning approaches hahm 17
Mmedsc Hahm
 
Ephs and nhp
Ephs and nhpEphs and nhp
Ephs and nhp
Mmedsc Hahm
 
Directing and leading 2017
Directing and leading 2017Directing and leading 2017
Directing and leading 2017
Mmedsc Hahm
 
Concepts of em
Concepts of emConcepts of em
Concepts of em
Mmedsc Hahm
 
Access to medicines p pt 17 10-2015
Access to medicines p pt 17 10-2015Access to medicines p pt 17 10-2015
Access to medicines p pt 17 10-2015
Mmedsc Hahm
 
The dynamics of disease transmission
The dynamics of disease transmissionThe dynamics of disease transmission
The dynamics of disease transmission
Mmedsc Hahm
 
Study designs dr.wah
Study designs dr.wahStudy designs dr.wah
Study designs dr.wah
Mmedsc Hahm
 
Standardization dr.wah
Standardization dr.wahStandardization dr.wah
Standardization dr.wah
Mmedsc Hahm
 
Randomized trials ii dr.wah
Randomized trials ii dr.wahRandomized trials ii dr.wah
Randomized trials ii dr.wah
Mmedsc Hahm
 

More from Mmedsc Hahm (20)

Solid waste-management-2858710
Solid waste-management-2858710Solid waste-management-2858710
Solid waste-management-2858710
 
Situation analysis
Situation analysisSituation analysis
Situation analysis
 
Quality in hospital
Quality in hospitalQuality in hospital
Quality in hospital
 
Patient satisfaction & quality in health care (16.3.2016) dr.nyunt nyunt wai
Patient satisfaction & quality in health care (16.3.2016) dr.nyunt nyunt waiPatient satisfaction & quality in health care (16.3.2016) dr.nyunt nyunt wai
Patient satisfaction & quality in health care (16.3.2016) dr.nyunt nyunt wai
 
Organising
OrganisingOrganising
Organising
 
Nscbl slide
Nscbl slideNscbl slide
Nscbl slide
 
Introduction to hahm 2017
Introduction to hahm 2017Introduction to hahm 2017
Introduction to hahm 2017
 
Hss lecture 2016 jan
Hss lecture 2016 janHss lecture 2016 jan
Hss lecture 2016 jan
 
Hospital management17
Hospital management17Hospital management17
Hospital management17
 
Hopital stat
Hopital statHopital stat
Hopital stat
 
Health planning approaches hahm 17
Health planning approaches hahm 17Health planning approaches hahm 17
Health planning approaches hahm 17
 
Ephs and nhp
Ephs and nhpEphs and nhp
Ephs and nhp
 
Directing and leading 2017
Directing and leading 2017Directing and leading 2017
Directing and leading 2017
 
Concepts of em
Concepts of emConcepts of em
Concepts of em
 
Access to medicines p pt 17 10-2015
Access to medicines p pt 17 10-2015Access to medicines p pt 17 10-2015
Access to medicines p pt 17 10-2015
 
The dynamics of disease transmission
The dynamics of disease transmissionThe dynamics of disease transmission
The dynamics of disease transmission
 
Study designs dr.wah
Study designs dr.wahStudy designs dr.wah
Study designs dr.wah
 
Standardization dr.wah
Standardization dr.wahStandardization dr.wah
Standardization dr.wah
 
Sdg
SdgSdg
Sdg
 
Randomized trials ii dr.wah
Randomized trials ii dr.wahRandomized trials ii dr.wah
Randomized trials ii dr.wah
 

Recently uploaded

Mastoid cavity problem and obilteration presentation by Dr Salison Salim Pani...
Mastoid cavity problem and obilteration presentation by Dr Salison Salim Pani...Mastoid cavity problem and obilteration presentation by Dr Salison Salim Pani...
Mastoid cavity problem and obilteration presentation by Dr Salison Salim Pani...
salisonsalim1
 
Veterinary Diagnostics Market PPT 2024: Size, Growth, Demand and Forecast til...
Veterinary Diagnostics Market PPT 2024: Size, Growth, Demand and Forecast til...Veterinary Diagnostics Market PPT 2024: Size, Growth, Demand and Forecast til...
Veterinary Diagnostics Market PPT 2024: Size, Growth, Demand and Forecast til...
IMARC Group
 
Luxurious Spa In Ajman Chandrima Massage Center
Luxurious Spa In Ajman Chandrima Massage CenterLuxurious Spa In Ajman Chandrima Massage Center
Luxurious Spa In Ajman Chandrima Massage Center
Chandrima Spa Ajman
 
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
o6ov5dqmf
 
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...
rightmanforbloodline
 
Trauma Outpatient Center .
Trauma Outpatient Center                       .Trauma Outpatient Center                       .
Trauma Outpatient Center .
TraumaOutpatientCent
 
RECENT ADVANCES IN BREAST CANCER RADIOTHERAPY
RECENT ADVANCES IN BREAST CANCER RADIOTHERAPYRECENT ADVANCES IN BREAST CANCER RADIOTHERAPY
RECENT ADVANCES IN BREAST CANCER RADIOTHERAPY
Isha Jaiswal
 
Bringing AI into a Mid-Sized Company: A structured Approach
Bringing AI into a Mid-Sized Company: A structured ApproachBringing AI into a Mid-Sized Company: A structured Approach
Bringing AI into a Mid-Sized Company: A structured Approach
Brian Frerichs
 
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.pptNursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Rommel Luis III Israel
 
The positive impact of SGRT – The Berkshire Cancer Centre experience
The positive impact of SGRT – The Berkshire Cancer Centre experienceThe positive impact of SGRT – The Berkshire Cancer Centre experience
The positive impact of SGRT – The Berkshire Cancer Centre experience
SGRT Community
 
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondEmpowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Health Catalyst
 
Tips for Pet Care in winters How to take care of pets.
Tips for Pet Care in winters How to take care of pets.Tips for Pet Care in winters How to take care of pets.
Tips for Pet Care in winters How to take care of pets.
Dinesh Chauhan
 
Artificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular TherapyArtificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular Therapy
Iris Thiele Isip-Tan
 
Rate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdfRate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdf
Rajarambapu College of Pharmacy Kasegaon Dist Sangli
 
Ginseng for Stamina Boost Your Energy and Endurance Naturally.pptx
Ginseng for Stamina Boost Your Energy and Endurance Naturally.pptxGinseng for Stamina Boost Your Energy and Endurance Naturally.pptx
Ginseng for Stamina Boost Your Energy and Endurance Naturally.pptx
SkyTagBioteq
 
PrudentRx's Function in the Management of Chronic Illnesses
PrudentRx's Function in the Management of Chronic IllnessesPrudentRx's Function in the Management of Chronic Illnesses
PrudentRx's Function in the Management of Chronic Illnesses
PrudentRx Program
 
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
Ameena Kadar
 
Cardiac Arrhythmias (2).pdf for nursing student
Cardiac Arrhythmias (2).pdf for nursing studentCardiac Arrhythmias (2).pdf for nursing student
Cardiac Arrhythmias (2).pdf for nursing student
fahmyahmed789
 
CCSN_June_06 2024_jones. Cancer Rehabpptx
CCSN_June_06 2024_jones. Cancer RehabpptxCCSN_June_06 2024_jones. Cancer Rehabpptx
CCSN_June_06 2024_jones. Cancer Rehabpptx
Canadian Cancer Survivor Network
 
Stem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac Care
Stem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac CareStem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac Care
Stem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac Care
Dr. David Greene Arizona
 

Recently uploaded (20)

Mastoid cavity problem and obilteration presentation by Dr Salison Salim Pani...
Mastoid cavity problem and obilteration presentation by Dr Salison Salim Pani...Mastoid cavity problem and obilteration presentation by Dr Salison Salim Pani...
Mastoid cavity problem and obilteration presentation by Dr Salison Salim Pani...
 
Veterinary Diagnostics Market PPT 2024: Size, Growth, Demand and Forecast til...
Veterinary Diagnostics Market PPT 2024: Size, Growth, Demand and Forecast til...Veterinary Diagnostics Market PPT 2024: Size, Growth, Demand and Forecast til...
Veterinary Diagnostics Market PPT 2024: Size, Growth, Demand and Forecast til...
 
Luxurious Spa In Ajman Chandrima Massage Center
Luxurious Spa In Ajman Chandrima Massage CenterLuxurious Spa In Ajman Chandrima Massage Center
Luxurious Spa In Ajman Chandrima Massage Center
 
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
 
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...
 
Trauma Outpatient Center .
Trauma Outpatient Center                       .Trauma Outpatient Center                       .
Trauma Outpatient Center .
 
RECENT ADVANCES IN BREAST CANCER RADIOTHERAPY
RECENT ADVANCES IN BREAST CANCER RADIOTHERAPYRECENT ADVANCES IN BREAST CANCER RADIOTHERAPY
RECENT ADVANCES IN BREAST CANCER RADIOTHERAPY
 
Bringing AI into a Mid-Sized Company: A structured Approach
Bringing AI into a Mid-Sized Company: A structured ApproachBringing AI into a Mid-Sized Company: A structured Approach
Bringing AI into a Mid-Sized Company: A structured Approach
 
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.pptNursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
 
The positive impact of SGRT – The Berkshire Cancer Centre experience
The positive impact of SGRT – The Berkshire Cancer Centre experienceThe positive impact of SGRT – The Berkshire Cancer Centre experience
The positive impact of SGRT – The Berkshire Cancer Centre experience
 
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondEmpowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
 
Tips for Pet Care in winters How to take care of pets.
Tips for Pet Care in winters How to take care of pets.Tips for Pet Care in winters How to take care of pets.
Tips for Pet Care in winters How to take care of pets.
 
Artificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular TherapyArtificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular Therapy
 
Rate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdfRate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdf
 
Ginseng for Stamina Boost Your Energy and Endurance Naturally.pptx
Ginseng for Stamina Boost Your Energy and Endurance Naturally.pptxGinseng for Stamina Boost Your Energy and Endurance Naturally.pptx
Ginseng for Stamina Boost Your Energy and Endurance Naturally.pptx
 
PrudentRx's Function in the Management of Chronic Illnesses
PrudentRx's Function in the Management of Chronic IllnessesPrudentRx's Function in the Management of Chronic Illnesses
PrudentRx's Function in the Management of Chronic Illnesses
 
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
 
Cardiac Arrhythmias (2).pdf for nursing student
Cardiac Arrhythmias (2).pdf for nursing studentCardiac Arrhythmias (2).pdf for nursing student
Cardiac Arrhythmias (2).pdf for nursing student
 
CCSN_June_06 2024_jones. Cancer Rehabpptx
CCSN_June_06 2024_jones. Cancer RehabpptxCCSN_June_06 2024_jones. Cancer Rehabpptx
CCSN_June_06 2024_jones. Cancer Rehabpptx
 
Stem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac Care
Stem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac CareStem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac Care
Stem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac Care
 

03. forecasting morbidity method

  • 1. FORECASTING MORBIDITY METHOD DR. MOE KYAW KYAW GHSC-PSM, MYANMAR MARCH, 2017
  • 2. Morbidity Method o Uses the frequency/ies of disease occurrence in the population or Incidence/prevalence of diseases o Requires standard treatment guidelines (STGs) o Best approach for justifying a budget request o Suitable for use where consumption data is not available o New treatment therapy, formulation, guideline, policies, new programs 2
  • 3. Data Requirement for Morbidity method • List of health commodities with minimum specifications • Morbidity data – o Target population, Incidence and/or prevalence of disease or frequency of the disease o Scaling up plan o Regimens and formulations used and respective proportions o Attrition Rates for chronic diseases • Standard treatment guidelines, including generic drug and dosing schedules 3
  • 4. Assumption and limitations – 1 4 Assumptions Limitations 1. The historical disease patterns remain the same in forecasted period  Not accurate for irregular disease pattern 2. Morbidity data/reports are accurate and comprehensive  Not accurate if reporting rate is low, the estimated disease frequency could be lower than actual
  • 5. Assumption and limitations – 2 5 Assumptions Limitations 3. Needs assumptions for • Scaling up plan and targets • Attrition rates • Failure rates • Proportion of treatments  Complex calculation especially for chronic diseases. Time consuming and computer analysis may need 4. STG exists and the treatment services follows the guideline  Not applicable if there is no STG  Not accurate, if the services do not follow the STG
  • 7. Step 1: Establish the list of medicines to be quantified Generic Names of medicines with minimum specifications of: ◦ Strength ◦ Basic Unit ◦ Form ◦ Accounting units ◦ Price per accounting unit Other specification for analysis ◦ Item categories ◦ VEN status ◦ Suppliers 7
  • 8. Step 2: Categorize the diseases to be addressed with this quantification Disease classification can be at different levels Example: Level 1 classification o Infectious, Non-infectious diseases Level 2 classification o Pneumonia, Malaria, TB o Hypertension, Diabetes 8
  • 9. Step 3: Calculating the Quantity required to treat an episode of the disease QE = DBU × ND × LD QE = Quantity needed for each treatment episode DBU = Basic units (of the product) per dose/administration ND = Number of doses per day •LD = Length of treatment in days DBU = DAD ÷ SPR DAD = Dosage per administration of medicine. E.g. 500mg SPR = Strength of product. E.g. 250mg 9
  • 10. Example for step 3 – Acute Cases One treatment for pneumonia includes o 500mg Amoxicillin, 3 times per day for 7 days o Available 250mg tablet QE = (DAD ÷ SPR) × ND × LD QE = (500 ÷ 250) x 3 x 7 QE = 2 x 3 x 7 = 42 tablets 10
  • 11. Example for step 3 – Chronic Cases (ARV) For regimen AZT/3TC/EFV o AZT+3TC (300+150)mg 2 times/day o EFV (600)mg 1 time/day AZT+3TC = 1 × 2 × 30 = 60 tabs/month EFV = 1 × 1 × 30 = 30 tabs/month 11
  • 12. Step 4: Calculate numbers of Estimated cases per month for each health condition during forecasted period For Acute Cases Incidence: # of new cases/diseases in a period Prevalence: # of all cases/diseases in a period Number of treatment (Episodes) Example: Prevalence of 12 cases/1,000 in 100,000 population Disease episodes = (12 x 100,000)/1,000 = 1200/yr Estimated cases per month (ECM) =1200/12 = 100 12
  • 13. Scaling-up for chronic cases (ARV) 13 10 20 30 40 Total patients treated per month (Patient-months)  10 10 10 10 10 10 10 10 10 10 Jan Feb Mar Apr Total person-months for all period  10+20+30+40 = 100 Number of ARVs = ARV/day x 30.5 x 100
  • 14. Step 5. Calculate the total quantity of each commodity required for the forecast period QT = ECM x FP x QE QT = Total quantities ECM = Expected Cases Per month FP = Forecast period in months QE = Quantity needed for each treatment episode E.g. 4 month forecast quantities for acute cases  QT = 100 x 4 X 42 = 16,800 tabs E.g. 4 month forecast quantities for chronic cases  QT for AZT/3TC = 100 x 60 = 6,000 tabs  QT for EFV = 100 x 1 x 30 = 3,000 tabs 14 42 tabs/ full treatment course AZT/3TC → 60 tabs/month EFV → 30 tabs/month
  • 15. Step 6: Calculate the cost of each commodity required for the period CT = QT x Unit Cost CT = Total cost of product for forecast period Example: CT for Amoxicillin 250mg cap = 16,800 x 20 = 33,600 Kyats 15